SEC Form 4 · accession 0001144204-15-037595
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Arvin Fink
Director
Period of report
Jun 16, 2015
Accepted (ET)
Jun 17, 2015 · 11:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.29 | Jun 16, 2015 | A | 20,000 | A | Jun 15, 2016 | Jun 15, 2025 | Common Stock | 20,000 | 30,000 | D |